SWHR Submits Letter to ICER on Draft Evidence Report for Fezolinetant


Published 11/8/22

The Society for Women’s Health Research sent a letter to the Institute for Clinical and Economic Review (ICER) in response to its Draft Evidence Report on Treatment for Vasomotor Symptoms Associated with Menopause. Central to SWHR’s comments were the points that access and affordability, the ability to engage in shared decision-making, and scientific innovation should be not just acknowledged, but valued and reflected in ICER’s final conclusion.

Read The Letter